Zhejiang Shengda Bio-Pharm Co., Ltd.
SSE:603079.SS
16.54 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 37.258 | -54.202 | 30.441 | 71.822 | 189.972 | 37.759 | 42.584 | 72.61 | 60.936 | 86.703 | 43.785 | 54.592 | 52.36 |
| Depreciation & Amortization
| 74.923 | 72.613 | 68.247 | 71.319 | 69.721 | 51.734 | 33.03 | 28.389 | 27.19 | 27.047 | 24.962 | 7.197 | 6.813 |
| Deferred Income Tax
| 0 | 0 | -1.088 | 0.595 | 3.253 | 0.971 | 0.796 | -0.429 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.511 | 0 | 0 | 28.102 |
| Change In Working Capital
| 14.728 | -13.519 | -57.916 | -73.03 | 30.08 | -58.453 | 2.8 | -19.237 | -15.425 | -13.43 | -42.722 | 0 | 0 |
| Accounts Receivables
| -45.289 | 36.492 | 10.761 | 250.69 | -15.734 | -25.261 | 24.94 | -56.863 | 27.632 | 0 | 0 | 0 | 0 |
| Inventory
| 19.373 | 23.376 | -87.933 | -63.049 | -6.593 | -75.867 | -13.2 | 21.879 | -17.68 | -39.493 | -24.7 | 0 | 0 |
| Accounts Payables
| 0 | -74.407 | 20.345 | -261.266 | 49.154 | 41.703 | -9.735 | 16.176 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 40.643 | 1.019 | -1.088 | 0.595 | 3.253 | 0.971 | 16 | -41.116 | 2.255 | 26.063 | -18.022 | 0 | 0 |
| Other Non Cash Items
| 20.97 | 59.53 | -0.055 | 4.35 | 43.429 | 27.513 | 10.272 | 13.572 | 0.301 | 47.752 | 8.376 | -54.592 | -52.36 |
| Operating Cash Flow
| 147.878 | 64.421 | 40.718 | 74.46 | 333.202 | 58.554 | 88.686 | 95.334 | 73.002 | 148.072 | 34.402 | 105.28 | 110.081 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -169.846 | -245.927 | -63.259 | -99.962 | -85.153 | -185.881 | -144.515 | -46.884 | -53.771 | -21.443 | -22.926 | -22.72 | -96.322 |
| Acquisitions Net
| 0 | -2.137 | -7 | 0.934 | 0.736 | 187.306 | -14.835 | 0.122 | 0.063 | -22.729 | -57.419 | 22.564 | 0.251 |
| Purchases Of Investments
| -291.551 | -25 | -370 | -238 | -199.2 | -96 | -15.5 | -105.5 | 0 | -10 | -18.3 | -48.91 | -10 |
| Sales Maturities Of Investments
| 275.724 | 32 | 351.393 | 339.574 | 160.299 | 31.698 | 93.081 | 15.024 | 0 | 10.408 | 18.37 | 21.924 | 6.397 |
| Other Investing Activites
| 1.308 | -0.454 | 0.533 | 0 | 1.163 | -185.881 | -0.887 | -2.246 | 1.806 | 1.027 | 0.708 | 3.292 | -6.109 |
| Investing Cash Flow
| -184.366 | -241.519 | -88.333 | 2.546 | -122.156 | -248.758 | -82.657 | -139.484 | -51.965 | -42.736 | -79.568 | -23.85 | -105.783 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 23.1 | 205.5 | -131.066 | -0.523 | -18.258 | 252.707 | 35.905 | -32.5 | 47.5 | -65.25 | -15.5 | -3.05 | -3 |
| Common Stock Issued
| 0 | -1.61 | 0 | 0 | 0 | 0 | 0 | -17.689 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -8.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -18.071 | -10.271 | -23.966 | -59.916 | -14.673 | -13.44 | -26.454 | -64.976 | -3.89 | -6.097 | -5.598 | -79.092 | -32.959 |
| Other Financing Activities
| -14.376 | -18.248 | 1.617 | 37.721 | -19.137 | -16.902 | 0 | 273.18 | -1.1 | -1 | 0 | 72.892 | 23.49 |
| Financing Cash Flow
| -9.347 | 176.98 | -156.878 | -22.718 | -52.068 | 214.592 | 9.451 | 158.015 | 42.51 | -72.347 | -21.098 | -9.25 | -12.469 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 3.475 | 2.629 | 17.828 | -6.671 | -17.909 | 2.73 | 5.35 | -4.933 | 5.968 | 3.015 | 0.017 | -0.171 | 0.068 |
| Net Change In Cash
| -42.359 | 2.512 | -186.666 | 47.617 | 141.069 | 27.118 | 20.83 | 108.932 | 69.515 | 36.004 | -66.248 | 72.008 | -8.103 |
| Cash At End Of Period
| 263.509 | 305.868 | 303.356 | 490.022 | 442.404 | 301.335 | 274.217 | 253.387 | 144.455 | 74.941 | 38.937 | 105.184 | 33.176 |